Clinical Treatment Experience in Severe and Critical COVID-19

Compared with other deadly diseases, the coronavirus disease 2019 (COVID-19) is highly infectious with a relatively low mortality rate. Although critical cases account for only 5% of cases, the mortality rate for the same is nearly 50%. Therefore, the key to the COVID-19 treatment is to effectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mingliang, Zhu, Donglin, Yang, Jianghua, Yan, Ling, Xiong, Zhiyong, Lu, Jiahai, Bi, Xiaogang, Xi, Yun, Chen, Zeliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483935/
https://www.ncbi.nlm.nih.gov/pubmed/34602859
http://dx.doi.org/10.1155/2021/9924542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483935/
https://www.ncbi.nlm.nih.gov/pubmed/34602859
http://dx.doi.org/10.1155/2021/9924542

Ejemplares similares